Half a century after its discovery, platelet-activating factor (PAF) is now recognized as a ferroptosis-activating phospholipid that contributes to tubule cell damage and nephron loss in acute kidney injury.
This is a preview of subscription content, log in via an institution to check access.
References
Zheng, J. & Conrad, M. Cell Metab. 32, 920–937 (2020).
Friedmann Angeli, J. P. et al. Nat. Cell Biol. 16, 1180–1191 (2014).
Linkermann, A. et al. Proc. Natl Acad. Sci. USA 111, 16836–16841 (2014).
Zhang, Q. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-023-01528-7 (2024).
Benveniste, J., Henson, P. M. & Cochrane, C. G. J. Exp. Med. 136, 1356–1377 (1972).
Demopoulos, C. A., Pinckard, R. N. & Hanahan, D. J. J. Biol. Chem. 254, 9355–9358 (1979).
Demopoulos, C. A. & Antonopoulou, S. Adv. Exp. Med. Biol. 416, 59–63 (1996).
McIntyre, T. M. Biochim. Biophys. Acta 1818, 2456–2464 (2012).
Kono, N. et al. J. Biol. Chem. 283, 1628–1636 (2008).
Zou, Y. et al. Nature 585, 603–608 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
B.P. is co-founder and shareholder of ROSCUE Therapeutics GmbH.
Rights and permissions
About this article
Cite this article
Zheng, J., Proneth, B. Chains of death. Nat Chem Biol (2024). https://doi.org/10.1038/s41589-023-01541-w
Published:
DOI: https://doi.org/10.1038/s41589-023-01541-w
- Springer Nature America, Inc.